Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
The Enhancement of Management of breast cancer in French speaking Sub-Saharan African Countries Release Date: Partner: AMFROM | Quality Improvement | Oncology | Benin, Congo, The Democratic Republic, Mali, Senegal, Togo | |
Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize Management Release Date: Partner: Beijing Guangda Precision Medicine Research Center | Quality Improvement | Inflammation & Immunology | China | |
Optimizing Antimicrobial Stewardship Program in Saudi Arabia Release Date: | Quality Improvement | Inflammation & Immunology | Saudi Arabia | |
Invasive Mold Infections (IMI) - Real-World Evidence from Treatment Outcomes with Isavuconazole Release Date: | Research | Inflammation & Immunology | Australia, Germany, Israel, Italy, Spain, Switzerland | |
PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer Release Date: | Education | Oncology | USA | |
Pediatric pneumococcal carriage and serotype distribution surveillance: prospective studies in South-East Asia, 2025-2026 Release Date: | Research | Vaccines | India, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam | |
Advancing Health Care Professionals’ knowledge and understanding of adult and maternal vaccination against respiratory infection Release Date: | Education | Vaccines | Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Ireland, Israel, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Slovenia, Ukraine | |
Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac era Release Date: | Research | Vaccines | Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of | |
The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRE Release Date: | Research | Hospital | China, Hong Kong | |
COVID-19 Disease Burden on the High Risk Population Release Date: | Education | Vaccines | All | |
New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel Disease Release Date: | Research | Inflammation & Immunology | USA |
Title | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
INNOVAtive Multi-disciplinary Clinical Management of INflammatory Diseases, 2023 IT INNOVA-MIND Release Date: | Quality Improvement | Inflammation & Immunology | Italy | |
Quality Improvement in Pediatric Endocrinology Fields Release Date: Partner: The Japanese Society for Pediatric Endocrinology | Quality Improvement | Rare Disease | Japan | |
Biomarker Testing / Lung Cancer Release Date: | Education | Oncology | Japan | |
Employment Support / Lung Cancer Release Date: | Education | Oncology | Japan | |
2023 Oncology Fellowship Release Date: | Fellowship | Oncology | Canada | |
Approaches to Implement Bispecific Antibodies into Clinical Practice, Increase Awareness and Improve Delivery of Quality of Care Release Date: Partner: Myeloma Canada | Quality Improvement | Oncology | Canada | |
Improving Health Equity via Clinical Trial Capability Development in China Release Date: | Education | Support for the Professions | China | |
Combination Therapy with Relugolix in the Treatment of Advanced Prostate Cancer Release Date: Partner: National Comprehensive Cancer Network; Myovant Sciences | Research | Oncology | USA | |
Optimizing Women’s Health Conditions in Canada Release Date: | Quality Improvement | Internal Medicine | Canada | |
Women’s Health Release Date: | Education | Internal Medicine | Canada | |
Accelerating Advancements in Women’s Health | Research | Internal Medicine | USA | |
Implementing Rapid Turnaround Time for NGS Molecular Testing for Cancer Patients in Non-Academic and Community Centres Release Date: Partner: Colorectal Cancer Canada and Thermo Fisher Scientific | Quality Improvement | Oncology | Canada |